Global Intravenous Iron Drugs Market Size study & Forecast, by Product (Iron Sucrose, Iron Dextran, Ferric Carboxymaltose, Others), by Application (Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer, Others) and Regional Analysis, 2023-2030
Global Intravenous Iron Drugs Market is valued at approximately USD 2.92 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.6% over the forecast period 2023-2030. Intravenous iron drugs are medications administered directly into the bloodstream to replenish iron stores in the body. They are used when oral iron supplements are ineffective or not suitable. These drugs help treat iron deficiency anemia by rapidly increasing iron levels in the body. The rising prevalence of chronic kidney disease, inflammatory bowel disease, and cancer, which are important indications for intravenous iron usage, is a significant driver for market growth. Additionally, the growing incidence of infectious diseases such as malaria, HIV/AIDS, TB, hepatitis, pneumonia, and influenza is expected to increase the demand for intravenous drugs in the future.
Moreover, the growing prevalence of cancer can support the growth of the Intravenous Iron Drugs Market. According to the WHO in 2022, Cancer, responsible for nearly 10 million deaths in 2020, remains a prominent global cause of mortality. In terms of new cases of cancer in 2020, the following were the most prevalent: Breast cancer accounted for 2.26 million cases, followed by lung cancer with 2.21 million cases, colon and rectum cancer with 1.93 million cases, prostate cancer with 1.41 million cases, non-melanoma skin cancer with 1.20 million cases, and stomach cancer with 1.09 million cases in 2020. Additionally, an growing investment in drugs development is anticipated to create the lucrative opportunity for the market during forecast period. However, adverse reactions associated with intravenous iron drugs stifling market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Intravenous Iron Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing prevalence of chronic kidney disease, gastrointestinal illnesses, and cancers in the region. Asia Pacific is expected to grow at fastest growth rate during the forecast period, owing to supportive government initiatives and the development of healthcare infrastructure. In addition, the high incidence of chronic kidney disease in developing nations such as China and India have aided market growth.
Major market player included in this report are:
CSL Limited
Covis Pharma GmbH
Daiichi Sankyo Company, Ltd.
Sanofi S.A.
Pharma cosmos A/S
Shield Therapeutics Plc
AbbVie Inc.
Rockwell Medical Inc
Americal Reagent Inc
Pfizer Inc.
Recent Developments in the Market:
In November 2022, Fer inject an intravenous iron therapy, obtained approval from China's National Medical Products Administration (NMPA). This approval allows CSL Vifor and Fresenius Kabi to utilize Fer inject for treating iron deficiency in adult patients who are unresponsive to oral iron preparations, unable to use them, or require rapid iron delivery due to clinical necessity.
In November 2022, a group of researchers funded by the National Institutes of Health (NIH) initiated a study to investigate the effectiveness of intravenous iron drug treatment for women with post-pregnancy anemia. The study aims to enrol approximately 5,000 women across multiple countries, including India, Bangladesh, Pakistan, the Democratic Republic of Congo, Kenya, Zambia, and Guatemala.
Global Intravenous Iron Drugs Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, Application, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Iron Sucrose
Iron Dextran
Ferric Carboxymaltose
Others
By Application:
Chronic Kidney Disease
Inflammatory Bowel Disease
Cancer
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Moreover, the growing prevalence of cancer can support the growth of the Intravenous Iron Drugs Market. According to the WHO in 2022, Cancer, responsible for nearly 10 million deaths in 2020, remains a prominent global cause of mortality. In terms of new cases of cancer in 2020, the following were the most prevalent: Breast cancer accounted for 2.26 million cases, followed by lung cancer with 2.21 million cases, colon and rectum cancer with 1.93 million cases, prostate cancer with 1.41 million cases, non-melanoma skin cancer with 1.20 million cases, and stomach cancer with 1.09 million cases in 2020. Additionally, an growing investment in drugs development is anticipated to create the lucrative opportunity for the market during forecast period. However, adverse reactions associated with intravenous iron drugs stifling market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Intravenous Iron Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing prevalence of chronic kidney disease, gastrointestinal illnesses, and cancers in the region. Asia Pacific is expected to grow at fastest growth rate during the forecast period, owing to supportive government initiatives and the development of healthcare infrastructure. In addition, the high incidence of chronic kidney disease in developing nations such as China and India have aided market growth.
Major market player included in this report are:
CSL Limited
Covis Pharma GmbH
Daiichi Sankyo Company, Ltd.
Sanofi S.A.
Pharma cosmos A/S
Shield Therapeutics Plc
AbbVie Inc.
Rockwell Medical Inc
Americal Reagent Inc
Pfizer Inc.
Recent Developments in the Market:
In November 2022, Fer inject an intravenous iron therapy, obtained approval from China's National Medical Products Administration (NMPA). This approval allows CSL Vifor and Fresenius Kabi to utilize Fer inject for treating iron deficiency in adult patients who are unresponsive to oral iron preparations, unable to use them, or require rapid iron delivery due to clinical necessity.
In November 2022, a group of researchers funded by the National Institutes of Health (NIH) initiated a study to investigate the effectiveness of intravenous iron drug treatment for women with post-pregnancy anemia. The study aims to enrol approximately 5,000 women across multiple countries, including India, Bangladesh, Pakistan, the Democratic Republic of Congo, Kenya, Zambia, and Guatemala.
Global Intravenous Iron Drugs Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, Application, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Iron Sucrose
Iron Dextran
Ferric Carboxymaltose
Others
By Application:
Chronic Kidney Disease
Inflammatory Bowel Disease
Cancer
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Intravenous Iron Drugs Market, by Region, 2020-2030 (USD Billion)
1.2.2. Intravenous Iron Drugs Market, by Product, 2020-2030 (USD Billion)
1.2.3. Intravenous Iron Drugs Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL INTRAVENOUS IRON DRUGS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL INTRAVENOUS IRON DRUGS MARKET DYNAMICS
3.1. Intravenous Iron Drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising Incidences of Chronic Kidney Disease
3.1.1.2. Growing incidence of infectious diseases
3.1.2. Market Challenges
3.1.2.1. Adverse reactions associated with intravenous iron drugs
3.1.3. Market Opportunities
3.1.3.1. Growing investment in drugs development
CHAPTER 4. GLOBAL INTRAVENOUS IRON DRUGS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL INTRAVENOUS IRON DRUGS MARKET, BY PRODUCT
5.1. Market Snapshot
5.2. Global Intravenous Iron Drugs Market by Product, Performance - Potential Analysis
5.3. Global Intravenous Iron Drugs Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Intravenous Iron Drugs Market, Sub Segment Analysis
5.4.1. Iron Sucrose
5.4.2. Iron Dextran
5.4.3. Ferric Carboxymaltose
5.4.4. Others
CHAPTER 6. GLOBAL INTRAVENOUS IRON DRUGS MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Intravenous Iron Drugs Market by Application, Performance - Potential Analysis
6.3. Global Intravenous Iron Drugs Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Intravenous Iron Drugs Market, Sub Segment Analysis
6.4.1. Chronic Kidney Disease
6.4.2. Inflammatory Bowel Disease
6.4.3. Cancer
6.4.4. Others
CHAPTER 7. GLOBAL INTRAVENOUS IRON DRUGS MARKET, REGIONAL ANALYSIS
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Intravenous Iron Drugs Market, Regional Market Snapshot
7.4. North America Intravenous Iron Drugs Market
7.4.1. U.S. Intravenous Iron Drugs Market
7.4.1.1. Product breakdown estimates & forecasts, 2020-2030
7.4.1.2. Application breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Intravenous Iron Drugs Market
7.5. Europe Intravenous Iron Drugs Market Snapshot
7.5.1. U.K. Intravenous Iron Drugs Market
7.5.2. Germany Intravenous Iron Drugs Market
7.5.3. France Intravenous Iron Drugs Market
7.5.4. Spain Intravenous Iron Drugs Market
7.5.5. Italy Intravenous Iron Drugs Market
7.5.6. Rest of Europe Intravenous Iron Drugs Market
7.6. Asia-Pacific Intravenous Iron Drugs Market Snapshot
7.6.1. China Intravenous Iron Drugs Market
7.6.2. India Intravenous Iron Drugs Market
7.6.3. Japan Intravenous Iron Drugs Market
7.6.4. Australia Intravenous Iron Drugs Market
7.6.5. South Korea Intravenous Iron Drugs Market
7.6.6. Rest of Asia Pacific Intravenous Iron Drugs Market
7.7. Latin America Intravenous Iron Drugs Market Snapshot
7.7.1. Brazil Intravenous Iron Drugs Market
7.7.2. Mexico Intravenous Iron Drugs Market
7.8. Middle East & Africa Intravenous Iron Drugs Market
7.8.1. Saudi Arabia Intravenous Iron Drugs Market
7.8.2. South Africa Intravenous Iron Drugs Market
7.8.3. Rest of Middle East & Africa Intravenous Iron Drugs Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. CSL Limited
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Covis Pharma GmbH
8.3.3. Daiichi Sankyo Company, Ltd.
8.3.4. Sanofi S.A.
8.3.5. Pharma cosmos A/S
8.3.6. Shield Therapeutics Plc
8.3.7. AbbVie Inc.
8.3.8. Rockwell Medical Inc
8.3.9. Americal Reagent Inc
8.3.10. Pfizer Inc.
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Intravenous Iron Drugs Market, by Region, 2020-2030 (USD Billion)
1.2.2. Intravenous Iron Drugs Market, by Product, 2020-2030 (USD Billion)
1.2.3. Intravenous Iron Drugs Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL INTRAVENOUS IRON DRUGS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL INTRAVENOUS IRON DRUGS MARKET DYNAMICS
3.1. Intravenous Iron Drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising Incidences of Chronic Kidney Disease
3.1.1.2. Growing incidence of infectious diseases
3.1.2. Market Challenges
3.1.2.1. Adverse reactions associated with intravenous iron drugs
3.1.3. Market Opportunities
3.1.3.1. Growing investment in drugs development
CHAPTER 4. GLOBAL INTRAVENOUS IRON DRUGS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL INTRAVENOUS IRON DRUGS MARKET, BY PRODUCT
5.1. Market Snapshot
5.2. Global Intravenous Iron Drugs Market by Product, Performance - Potential Analysis
5.3. Global Intravenous Iron Drugs Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Intravenous Iron Drugs Market, Sub Segment Analysis
5.4.1. Iron Sucrose
5.4.2. Iron Dextran
5.4.3. Ferric Carboxymaltose
5.4.4. Others
CHAPTER 6. GLOBAL INTRAVENOUS IRON DRUGS MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Intravenous Iron Drugs Market by Application, Performance - Potential Analysis
6.3. Global Intravenous Iron Drugs Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Intravenous Iron Drugs Market, Sub Segment Analysis
6.4.1. Chronic Kidney Disease
6.4.2. Inflammatory Bowel Disease
6.4.3. Cancer
6.4.4. Others
CHAPTER 7. GLOBAL INTRAVENOUS IRON DRUGS MARKET, REGIONAL ANALYSIS
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Intravenous Iron Drugs Market, Regional Market Snapshot
7.4. North America Intravenous Iron Drugs Market
7.4.1. U.S. Intravenous Iron Drugs Market
7.4.1.1. Product breakdown estimates & forecasts, 2020-2030
7.4.1.2. Application breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Intravenous Iron Drugs Market
7.5. Europe Intravenous Iron Drugs Market Snapshot
7.5.1. U.K. Intravenous Iron Drugs Market
7.5.2. Germany Intravenous Iron Drugs Market
7.5.3. France Intravenous Iron Drugs Market
7.5.4. Spain Intravenous Iron Drugs Market
7.5.5. Italy Intravenous Iron Drugs Market
7.5.6. Rest of Europe Intravenous Iron Drugs Market
7.6. Asia-Pacific Intravenous Iron Drugs Market Snapshot
7.6.1. China Intravenous Iron Drugs Market
7.6.2. India Intravenous Iron Drugs Market
7.6.3. Japan Intravenous Iron Drugs Market
7.6.4. Australia Intravenous Iron Drugs Market
7.6.5. South Korea Intravenous Iron Drugs Market
7.6.6. Rest of Asia Pacific Intravenous Iron Drugs Market
7.7. Latin America Intravenous Iron Drugs Market Snapshot
7.7.1. Brazil Intravenous Iron Drugs Market
7.7.2. Mexico Intravenous Iron Drugs Market
7.8. Middle East & Africa Intravenous Iron Drugs Market
7.8.1. Saudi Arabia Intravenous Iron Drugs Market
7.8.2. South Africa Intravenous Iron Drugs Market
7.8.3. Rest of Middle East & Africa Intravenous Iron Drugs Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. CSL Limited
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Covis Pharma GmbH
8.3.3. Daiichi Sankyo Company, Ltd.
8.3.4. Sanofi S.A.
8.3.5. Pharma cosmos A/S
8.3.6. Shield Therapeutics Plc
8.3.7. AbbVie Inc.
8.3.8. Rockwell Medical Inc
8.3.9. Americal Reagent Inc
8.3.10. Pfizer Inc.
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Intravenous Iron Drugs Market, report scope
TABLE 2. Global Intravenous Iron Drugs Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Intravenous Iron Drugs Market estimates & forecasts by Product 2020-2030 (USD Billion)
TABLE 4. Global Intravenous Iron Drugs Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Intravenous Iron Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Intravenous Iron Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Intravenous Iron Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Intravenous Iron Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Intravenous Iron Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Intravenous Iron Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Intravenous Iron Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Intravenous Iron Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Intravenous Iron Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Intravenous Iron Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Intravenous Iron Drugs Market
TABLE 70. List of primary sources, used in the study of global Intravenous Iron Drugs Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Intravenous Iron Drugs Market, report scope
TABLE 2. Global Intravenous Iron Drugs Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Intravenous Iron Drugs Market estimates & forecasts by Product 2020-2030 (USD Billion)
TABLE 4. Global Intravenous Iron Drugs Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Intravenous Iron Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Intravenous Iron Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Intravenous Iron Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Intravenous Iron Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Intravenous Iron Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Intravenous Iron Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Intravenous Iron Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Intravenous Iron Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Intravenous Iron Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Intravenous Iron Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Intravenous Iron Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Intravenous Iron Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Intravenous Iron Drugs Market
TABLE 70. List of primary sources, used in the study of global Intravenous Iron Drugs Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Intravenous Iron Drugs Market, research methodology
FIG 2. Global Intravenous Iron Drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Intravenous Iron Drugs Market, key trends 2022
FIG 5. Global Intravenous Iron Drugs Market, growth prospects 2023-2030
FIG 6. Global Intravenous Iron Drugs Market, porters 5 force model
FIG 7. Global Intravenous Iron Drugs Market, pest analysis
FIG 8. Global Intravenous Iron Drugs Market, value chain analysis
FIG 9. Global Intravenous Iron Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Intravenous Iron Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Intravenous Iron Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Intravenous Iron Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Intravenous Iron Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Intravenous Iron Drugs Market, regional snapshot 2020 & 2030
FIG 15. North America Intravenous Iron Drugs Market 2020 & 2030 (USD Billion)
FIG 16. Europe Intravenous Iron Drugs Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Intravenous Iron Drugs Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Intravenous Iron Drugs Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Intravenous Iron Drugs Market 2020 & 2030 (USD Billion)
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Intravenous Iron Drugs Market, research methodology
FIG 2. Global Intravenous Iron Drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Intravenous Iron Drugs Market, key trends 2022
FIG 5. Global Intravenous Iron Drugs Market, growth prospects 2023-2030
FIG 6. Global Intravenous Iron Drugs Market, porters 5 force model
FIG 7. Global Intravenous Iron Drugs Market, pest analysis
FIG 8. Global Intravenous Iron Drugs Market, value chain analysis
FIG 9. Global Intravenous Iron Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Intravenous Iron Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Intravenous Iron Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Intravenous Iron Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Intravenous Iron Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Intravenous Iron Drugs Market, regional snapshot 2020 & 2030
FIG 15. North America Intravenous Iron Drugs Market 2020 & 2030 (USD Billion)
FIG 16. Europe Intravenous Iron Drugs Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Intravenous Iron Drugs Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Intravenous Iron Drugs Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Intravenous Iron Drugs Market 2020 & 2030 (USD Billion)
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
